NFKB1 and acute respiratory distress syndrome: Kaempferol can reduce septic ARDS inflammation by inhibiting the HIF-1α, NF-κB, and PI3K-Akt pathways in alveolar macrophages, thereby decreasing inflammation and apoptosis.